Ipca Laboratories Interview : Production, Quality Control, Formulation Injection Jobs
8 July 2026

Ipca Laboratories Interview : Production, Quality Control, Formulation Injection Jobs

Supervises vial manufacturing activities, including dispensing, washing, sterilization, and filling. Manages online documentation for logbooks, BMRs, and BPRs. Executes change controls via TrackWise and updates SOPs, URS, and Quality Risk Assessments to ensure regulatory compliance.
Interview for Pharma candidates in Manufacturing and Packing at Sun Pharma
8 July 2026
Interview for Pharma candidates in Manufacturing and Packing at Sun Pharma
Sun Pharma is Indias No. 1 pharmaceutical company and a leading global player in specialty medicines.
Regulatory Affairs Jobs at PAREXEL - MPharm, BPharm, MSc Apply
8 July 2026
Regulatory Affairs Jobs at PAREXEL - MPharm, BPharm, MSc Apply
This role focuses on managing post-approval regulatory activities, including variations, renewals, and compliance with country-specific requirements. You will partner with cross-functional teams to ensure timely submissions and maintain regulatory dossiers.
Pivot Path Hiring Associate / Senior Associate / Trainee
8 July 2026
Pivot Path Hiring Associate / Senior Associate / Trainee
Support system implementation, upgrades, and change management. Work with clients and crosse Functional teams to ensure regulatory compliance 
Interview for Pharma and Science candidates in Bioanalytical Lab at Cliantha Research
8 July 2026
Interview for Pharma and Science candidates in Bioanalytical Lab at Cliantha Research
Ensure the report is prepared as per the respective regulatory and sponsor requirements. Handle sponsors or regulatory queries on lab reports.
IPA Urges Government to Revise Draft National Pharmacy Commission Bill Before Parliament
8 July 2026
IPA Urges Government to Revise Draft National Pharmacy Commission Bill Before Parliament

The Indian Pharmacist Association (IPA) has submitted a detailed representation to Union Health Minister Jagat Prakash Nadda, urging the Government of India to comprehensively revise the Draft National Pharmacy Commission (NPC) Bill, 2026 before it is introduced in Parliament. The association has also separately requested the Ministry of Health & Family Welfare to issue nationwide implementation directions for the recently notified Pharmacist Recruitment, Promotion and Service Regulations.

Government Adds Navi Mumbai Airport to India's Approved Drug Import Network Under Drugs Rules
8 July 2026
Government Adds Navi Mumbai Airport to India's Approved Drug Import Network Under Drugs Rules

The Central Government has officially amended the Drugs Rules, 1945, allowing Navi Mumbai Airport to be used as an authorized entry point for the import of drugs into India. The amendment has been notified through the Drugs (Ninth Amendment) Rules, 2026, which came into force upon its publication in the Official Gazette.

Marksans Pharma to acquire Germany-Based ABCnow GmbH to Strengthen European Market Presence
8 July 2026
Marksans Pharma to acquire Germany-Based ABCnow GmbH to Strengthen European Market Presence

Marksans Pharma Ltd. has announced the acquisition of 100% share capital of ABCnow GmbH, a Germany-based pharmaceutical wholesale and distribution company, in a strategic move to strengthen its presence across regulated European markets. The company has entered into a definitive agreement to acquire the business as part of its forward integration strategy.

The acquisition will be completed through a cash consideration of €892,384, with the transaction expected to close by July 31, 2026. Marksans stated that no government or regulatory approvals are required for the acquisition.

Vertex to Acquire Crinetics Pharmaceuticals in USD 10 Billion Deal to Expand Rare Disease Portfolio
8 July 2026
Vertex to Acquire Crinetics Pharmaceuticals in USD 10 Billion Deal to Expand Rare Disease Portfolio
Vertex Pharmaceuticals has announced a definitive agreement to acquire Crinetics Pharmaceuticals in an all-cash transaction valued at approximately USD 10 billion.
US FDA Approves Trutakna, a New Treatment for IgA Nephropathy to Reduce Proteinuria
8 July 2026
US FDA Approves Trutakna, a New Treatment for IgA Nephropathy to Reduce Proteinuria

The U.S. Food and Drug Administration (FDA) has approved Trutakna (atacicept-vymj) to reduce proteinuria (excess protein in the urine) in adults with primary Immunoglobulin A nephropathy (IgAN) who are at risk of disease progression. The approval provides a new treatment option for patients with this rare kidney disease, which can eventually lead to kidney failure.